Rating Change
Keefe, Bruyette & Woods reiterated its Outperform rating on MetLife, Inc. (NYSE:MET) on August 11, 2026.
reiterateNYSE:MET
Keefe, Bruyette & Woods Reiterates Outperform Rating on MetLife, Inc. (MET)
Keefe, Bruyette & Woods reiterated its Outperform rating on MetLife, Inc. (NYSE:MET) on August 11, 2026.
At publication ·
What changed
MetLife, Inc. (NYSE:MET) · reiterate
- Firm
- Keefe, Bruyette & Woods
- Rating
- Outperform to Outperform
- Price at event
- $96.80
- Market capitalization
- $54.2B
At a glance
Key takeaways
- Keefe, Bruyette & Woods reiterated an Outperform rating on MetLife on August 11, 2026, with the stock trading at $96.80 and a market capitalization of $54.2 billion.
Market Context
MetLife, Inc. operates in the Financial Services sector. The stock currently trades at $96.80 with a market capitalization of $54.2B. The stock has gained 29.2% over the past 52 weeks.
Analyst coverage from Keefe, Bruyette & Woods provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MetLife, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for MetLife, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 11, 2026 | JP Morgan | Overweight | N/A |
| Aug 11, 2026 | Keefe, Bruyette & Woods | Outperform | N/A |
| Aug 06, 2026 | Barclays | Overweight | N/A |
| Jul 22, 2026 | TD Cowen | Buy | N/A |
| Jul 21, 2026 | JP Morgan | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View MET Stock Page
Frequently Asked Questions
What does the Outperform rating mean for MET?
A rating of Outperform from Keefe, Bruyette & Woods reflects the analyst's outlook on MetLife, Inc. (NYSE:MET). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MET forecast page.
